The UK Imaging and Oncology Congress (UKIO) – the UK’s largest multidisciplinary event in the field – returns in person in July 2022.
After two years of a fully online event, we’re excited to be back in Liverpool with a refreshed congress. As always the event will offer three days of education and CPD with a programme that showcases the most cutting-edge content for a multidisciplinary audience that addresses the medical, scientific, educational and management issues in the diverse fields of diagnostic imaging, oncology, and radiological sciences. Alongside this is a large professional exhibition of the latest state-of-the-art equipment, services and technology available in the industry.
With the return of the in-person congress comes an opportunity to refresh and rebuild the event. As we plan for 2022, we’ll be focussing on:
• An emphasis on networking.
• Practical and hands-on sessions.
• Case-study and discussion-led content.
• Content for trainees.
• Generalist and skills mix sessions.
• An interactive exhibition.
UKIO is the place to be for practice-based content and networking. Join us in Liverpool as we come back together – meet old friends and new, join up with like-minded professionals and meet with people who just might help you change your service.
UKIO is just a few weeks away! Read a message from the President for a summary of the exciting things we have planned.
We are running pre-congress webinars – added-value content to enhance your in-person attendance. These can also be accessed on a digital-only ticket.
The programme is available. Take a look at what’s planned so far and keep an eye out for updates as we add sessions.
Registration is open!
Exhibition visitor tickets are available at no cost to NHS employees, that give access to the exhibition and a small number of sessions.
Digital-only tickets are available at no cost, that give access to some selected features on the hybrid congress platform.
Details of the social programme are available now – find out more about the programme and book tickets.